神经刺激治疗儿童非神经源性膀胱过度活动症的Meta分析
该Meta分析纳入5项随机对照试验共245例患儿,评估神经刺激治疗儿童非神经源性膀胱过度活动症的疗效与安全性。与标准泌尿治疗相比,神经刺激在≥50%应答率上显著更优(RR=2.8,95%CI 1.1-7.2),但≥90%应答率无显著差异(RR=8.28,95%CI 0.65-105.92)。诊室操作神经刺激在≥50%和≥90%应答上均显著更优,而自我操作方案无显著差异;未报告严重不良事件。
要点
- 与标准泌尿治疗相比,神经刺激改善≥50%应答(RR=2.8,95%CI 1.1-7.2)。
- 诊室神经刺激的≥50%和≥90%应答均显著优于对照。
- 自我操作神经刺激的≥50%和≥90%应答与对照无显著差异。
核心结论
- 神经刺激可能改善儿童非神经源性膀胱过度活动症的部分缓解,但可能无法实现确定的完全缓解。
- 诊室操作神经刺激似乎比自我操作神经刺激更有效。
- 需要进一步随机对照试验比较两种方案的结果。
研究设计与样本
- 随机对照试验的Meta分析,系统文献检索于2016年8月进行。
- 共纳入5项符合条件的研究,245例患者。
- 采用Cochrane协作网偏倚风险评估工具评价随机对照试验。
- 当存在显著研究间异质性(P<.1)时,采用Mantel-Haenszel法随机效应模型合并效应估计。
- 按每种治疗设置进行亚组分析(PROSPERO CRD42016043502)。
主要发现
- 与标准泌尿治疗相比,神经刺激的≥50%(部分缓解+完全缓解+完全应答)应答显著更优(RR=2.8,95%CI 1.1-7.2)。
- 与标准泌尿治疗相比,神经刺激的≥90%(完全缓解+完全应答)应答无显著差异(RR=8.28,95%CI 0.65-105.92)。
- 诊室神经刺激的≥50%应答显著更优(RR=3.24,95%CI 1.89-5.57),≥90%应答也显著更优(RR=20.81,95%CI 2.97-145.59)。
- 自我操作方案的≥50%应答无显著差异(RR=2.61,95%CI 0.48-14.15),≥90%应答也无显著差异(RR=3.55,95%CI 0.19-67.82)。
- 未报告严重不良事件。
关键数值与推荐
- 部分缓解定义为50%-89%应答,完全缓解定义为≥90%应答,完全应答定义为100%应答。
- 总体≥50%应答为部分缓解+完全缓解+完全应答,≥90%应答为完全缓解+完全应答。
临床怎么用
- 作者认为神经刺激可能改善儿童非神经源性膀胱过度活动症的部分缓解,但可能无法实现确定的完全缓解。
- 作者认为诊室操作神经刺激似乎比自我操作神经刺激更有效。
- 作者建议需要进一步随机对照试验比较两种方案的结果。
局限性
- 需要进一步随机对照试验比较两种方案的结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the efficacy and safety of neurostimulation for non-neurogenic overactive bladder in children, we conducted a meta-analysis of randomized controlled trials (RCTs). MATERIALS AND METHODS: A systematic literature search was performed on August 2016. RCTs were evaluated according to the Cochrane Collaboration risk of bias assessment. Number of patients with post-treatment partial response (PR) (50%-89%), complete response (CR) (≥90%), and full response (FR) (100%) were extracted for relative risk (RR) and 95% confidence interval (CI). Effect estimates were pooled using the Mantel-Haenszel method with random effect model if significant inter-study heterogeneity (P <.1) was noted. Subgroup analysis was performed according to each treatment setting (PROSPERO CRD42016043502). RESULTS: Five eligible studies (245 patients) were included. Overall effect estimates showed that compared with standard urotherapy, neurostimulation demonstrated significantly better ≥50% (PR + CR + FR) response (RR = 2.8, 95% CI 1.1-7.2), but not ≥90% (CR + FR) response (RR = 8.28, 95% CI 0.65-105.92). Clinic-based neurostimulation had significantly better treatment outcomes for both ≥50% (PR + CR + FR) and ≥90% (CR + FR) responses (RR = 3.24, 95% CI 1.89-5.57; RR = 20.81, 95% CI 2.97-145.59, respectively), whereas a self-administered regimen showed no differences for both ≥50% (PR + CR + FR) and ≥90% (CR + FR) response rates between treatment groups (RR = 2.61, 95% CI 0.48-14.15; RR = 3.55, 95% CI 0.19-67.82, respectively). No serious adverse events were reported. CONCLUSION: Neurostimulation therapy may lead to better partial improvement of non-neurogenic overactive bladder; however, it may not render a definitive complete response. Office-based neurostimulation seems more efficacious than self-administered neurostimulation. Further RCTs are needed to compare outcomes of the 2 regimens.
引用
- Fernandez N, Chua ME, Ming JM, et al. Neurostimulation Therapy for Non-neurogenic Overactive Bladder in Children: A Meta-analysis. Urology. 2017. PMID: 28823638. doi:10.1016/j.urology.2017.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。